Flexcin By Flexcin International Overview & Drug Interactions

Check For Interactions With Flexcin

Supplement: Flexcin by Flexcin International

Flexcin Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Flexcin by Flexcin International

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
4 Capsule(s)
Maximum serving Sizes:
4 Capsule(s)
Servings per container 30
UPC/BARCODE 89649800048

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin C
100 mg
Vitamin C (ascorbic acid) 167%
Calcium Citrate, Powder
20 mg
Calcium 1%
Zinc Amino Acid Chelate
11.3 mg
Zinc 1%
Copper Chelate
3 mg
Copper 1%
Manganese Chelate
5 mg
Manganese 50%
Proprietary Blend
2317.36 mg
Proprietary Blend --
Cetyl Myristoleate
0 NP
Cetyl Myristoleate
Glucosamine Sulfate Potassium
0 NP
Glucosamine Sulfate
Collagen Type II
0 NP
Collagen
Methylsulfonylmethane
0 NP
Methylsulfonylmethane
Peppermint leaf powder
0 NP
Peppermint
Bromelain
0 NP
Bromelain
Protease
0 NP
Proteolytic Enzymes (Proteases)
Amylase
0 NP
Amylase
Cellulase
0 NP
Cellulase
Invertase
0 NP
Sucrase
Lipase
0 NP
Lipase
Boorganic Complex
0 NP
Blend

Other Ingredients:
Magnesium Stearate
Maltodextrin
Silica
Vegetable capsule


Label Statments:


Formula
- Flexcin contains CM8 (Cetyl Myristoleate). It is an all natural compound that has been clinically proven to promote optimal joint health. The combination of ingredients in Flexcin is specifically formulated to help nourish the joints, support healthy cartilage and increase mobility.
- Flexcin with CM8 (Cetyl Myristoleate) for joint health & mobility
Suggested/Recommended/Usage/Directions
- Take one serving of 4 capsules daily with a glass of water and/or a meal or 2 capsules in the morning and 2 capsules in the evening. Persons with severe joint conditions may increase the dosage to 1 1/2 servings (6 capsules) daily for the first 2 weeks or until joint condition improves then resume back to the regular serving size of 4 capsules a day.
Precautions
- Keep out of reach of children
- Do not use if pregnant or nursing
- Do not use if tamper evident safety neck seal is broken or missing
Storage
- Protect from light, heat & moisture Store in a cool, dry place
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Brand IP Statement(s)
- CM8 is a registered trademark of Flexcin International, Inc. Cetyl Myristoleate (US Patents 4,049,824; 4,113,881: 5,569676)
Seals/Symbols
- Made in USA
General Statements
- 30 day supply
FDA Statement of Identity
- Dietary Supplement
Formulation
- Extra strength Load-up formula
- Contains no: Gluten, sugar, dairy products, yeast, wheat, artificial color, artificial flavoring or preservatives. GMO free

Brand Information

See all products by this brand

Manufactured Exclusively For
Name Flexcin International, Inc.
Street Address 1030 SE 9th Ave #152605
City Cape Coral
State FL
ZipCode 33915
Phone Number (800) 505-0575
Web Address Flexcin.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.